AIRS
AirSculpt Technologies, Inc.
NASDAQ · Healthcare · Medical - Care Facilities · US
$2.80
+10.04%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 150.7M | 151.8M | 180.3M | 195.9M | 168.8M |
| Cost of Revenue | 63.9M | 61.7M | 71.4M | 74.0M | 58.3M |
| Gross Profit | 86.9M | 90.1M | 109.0M | 121.9M | 110.5M |
| Operating Expenses | |||||
| R&D Expense | — | — | — | — | — |
| SG&A Expense | 86.5M | 82.2M | 105.6M | 108.3M | 105.9M |
| General & Admin Expense | 39.3M | — | 72.2M | 82.4M | 85.3M |
| Selling & Marketing Expense | 6.4M | — | 33.4M | 25.9M | 20.6M |
| Other Expenses | 12.2M | 12.8M | 5.2M | 4.1M | 9.1M |
| Total Operating Expenses | 98.7M | 95.0M | 110.8M | 112.4M | 115.1M |
| Cost and Expenses | 162.6M | 156.7M | 182.2M | 186.4M | 173.3M |
| Operating Income (EBIT) | (11.8M) | (4.8M) | (1.8M) | 9.5M | (4.5M) |
| Non-Operating | |||||
| Interest Income | — | — | — | — | — |
| Interest Expense | 5.1M | 6.1M | 6.2M | 6.5M | 6.8M |
| Net Interest Income | (5.1M) | (6.1M) | (6.2M) | (6.5M) | (6.8M) |
| Other Non-Op Income/Expense | (2.6M) | (12.8M) | (6.2M) | (6.5M) | (6.8M) |
| Non-Operating Income (excl Interest) | (3.0M) | 6.7M | — | — | (1.1M) |
| EBT (Pre-Tax Income) | (14.4M) | (17.6M) | (8.1M) | 3.0M | (11.3M) |
| Income Tax Expense | (2.7M) | (6.0M) | 188.0K | 7.5M | 3.4M |
| Bottom Line | |||||
| Net Income | (11.7M) | (11.7M) | (8.3M) | (4.5M) | (14.7M) |
| Earnings from Cont. Ops | (11.7M) | (11.7M) | (8.3M) | (4.5M) | (14.7M) |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | (11.7M) | (11.7M) | (8.3M) | (4.5M) | (14.7M) |
| Per Share | |||||
| Basic EPS | ($0.18) | ($0.19) | ($0.14) | ($0.08) | ($0.26) |
| Diluted EPS | ($0.18) | ($0.19) | ($0.14) | ($0.08) | ($0.26) |
| Revenue Per Share | $2.13 | $2.51 | $3.13 | $3.45 | $3.03 |
| Shares | |||||
| Basic Shares Outstanding | 70.8M | 60.5M | 57.7M | 56.8M | 55.7M |
| Diluted Shares Outstanding | 70.8M | 60.5M | 57.7M | 56.8M | 55.7M |
| Profitability Metrics | |||||
| EBITDA | 3.4M | 1.2M | 10.1M | 19.7M | 4.6M |
| D&A | 12.3M | 12.8M | 11.9M | 10.3M | 8.1M |
| EBIT | (8.8M) | (11.6M) | (1.8M) | 9.5M | (3.5M) |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026